Latest news
Travere Therapeutics (TVTX) On Q2 Results And FILSPARI Hopes As Fair Value Stays In View - Yahoo Finance SingaporeYahoo Finance Singapore · Fri, 07 Aug 2026 04:29:00 GMTDoes FILSPARI-Driven Revenue Growth And Wider Losses Change The Bull Case For Travere Therapeutics (TVTX)? - webull.comwebull.com · Thu, 06 Aug 2026 17:56:19 GMTTravere Therapeutics Reports Second Quarter 2026 Financial Results - Business WireBusiness Wire · Tue, 04 Aug 2026 20:01:00 GMT